To include your compound in the COVID-19 Resource Center, submit it here.
Merck & Co. Inc. (NYSE:MRK) partnered with Cue Biopharma Inc. (Cambridge, Mass.) to develop biologics to treat autoimmune
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury